COUNCIL MEMBERS
|
Chair, 2008-2010
Bryan Luce MBA, PhD
Senior Vice President, Science Policy
United BioSource Corporation
Bethesda, MD, USA
|
|
Lieven Annemans PhD, MSc, Mman
Professor and Senior Consultant, Ghent University
HEDM and IMS Health
Meise, Belgium |
|
Diana Brixner PhD
Professor and Executive Director,
Pharmacotherapy Outcomes Research Center
University of Utah, College of Pharmacy
Salt Lake City, UT, USA |
|
Jon Clouse MS, RPh
Director, Pharmacoeconomic Evaluations
United Health Care
Brevard,
NC, USA |
|
Michael Drummond PhD,
Professor of Health Economics
University of York,
Heslington, York, UK |
|
Jean Paul Gagnon PhD, RPh
Director, Public Policy,
Aventis Pharmaceuticals Inc
Bridgewater, NJ, USA |
|
Joel Hay PhD
Associate Professor,
USC Dept. of Pharmaceutical Economics & Policy
Los Angeles, CA, USA |
|
Kathleen N. Lohr PhD, MPhil, MA
Director, Health Services and Policy Research
RTI International
Research Triangle Park, NC USA |
|
William McGhan PharmD, PhD
Professor of Pharmacy and Health Policy
Univeristy of the Sciences
Philadelphia, PA, USA |
|
Peter J. Neumann, ScD
Director, Center for the Evaluation of Value and Risk in Health
Professor, Tufts University School of Medicine Institute for Clinical Research and Health Policy Studies,
Tufts-New England Medical Center
Boston, MA, USA |
|
Jim Smeeding MBA, RPh
President, JestaRx Group
Dallas, TX, USA |
|
Sean Sullivan PhD, RPh, MS
Professor and Director, University of Washington,
Pharmaceutical Outcomes Research and Policy Program
Seattle, WA, USA |
|
John E. Ware, Jr. PhD
CEO, Chief Science Officer &
Chairman of the Board, QualityMetric Inc.
Lincoln, RI, USA |
|
Milton Weinstein PhD
Professor Health Policy & Management, Harvard School of Public Health
Boston, MA, USA |
IHSPC main page
|
|
|
|
